- Home
- BBNX
as 11-14-2025 3:41pm EST
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | IRVINE |
| Market Cap: | 967.6M | IPO Year: | 2025 |
| Target Price: | $28.09 | AVG Volume (30 days): | 793.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.89 - $30.47 | Next Earning Date: | 10-28-2025 |
| Revenue: | $88,570,000 | Revenue Growth: | 67.01% |
| Revenue Growth (this year): | 52.13% | Revenue Growth (next year): | 36.07% |
Latest Beta Bionics Inc. Common Stock News
BBNX Breaking Stock News: Dive into BBNX Ticker-Specific Updates for Smart Investing
GuruFocus.com
17 days ago
Beta Bionics Inc (BBNX) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Challenges
Simply Wall St.
17 days ago
Beta Bionics (BBNX) Valuation Concerns Mount as Forecast Revenue Growth Far Exceeds Market Average
Simply Wall St.
17 days ago
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10
MT Newswires
18 days ago
Truist Raises Price Target on Beta Bionics to $32 From $28, Keeps Buy Rating
Motley Fool
18 days ago
Beta Bionics (BBNX) Q3 2025 Earnings Transcript
Zacks
19 days ago
Beta Bionics, Inc. (BBNX) Reports Q3 Earnings: What Key Metrics Have to Say
GlobeNewswire
19 days ago
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
GuruFocus.com
20 days ago
What to Expect from Beta Bionics Inc (BBNX) Q3 2025 Earnings
Compare BBNX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BBNX Beta Bionics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.